Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal …
Biotechnology
US, New York [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Protagenic Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Protagenic Therapeutics, Inc. has no acquisition track records yet.